Released Jan 29, 2016, after the close
10-K filed Jan 29, 2016, 90 days after period end · 0001354488-16-006025
Q4 2015 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income$523.45K$523.45K derived−36.7% vs Q4 2014+15.3% vs Q3 2015
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$2,046,875−12.3%
Operating Incomederived$565,586−38.5%
Operating Cash Flowderived$1,171,918−14.2%
Free Cash Flowderived$931,833−29.9%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures |
|---|---|---|---|---|
| Net Income | $523.45K | $826.87K | $1.22M | $1.08M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR